These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2907574)

  • 1. Concentration and time-dependent inter-relationships for cytotoxicities of nitrogen mustard drugs against lymphoblasts in-vitro.
    Ehrsson H; Wallin I; Ringborg U
    J Pharm Pharmacol; 1988 Dec; 40(12):834-7. PubMed ID: 2907574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aneugenic potential of the nitrogen mustard analogues melphalan, chlorambucil and p-N,N-bis(2-chloroethyl)aminophenylacetic acid in cell cultures in vitro.
    Efthimiou M; Andrianopoulos C; Stephanou G; Demopoulos NA; Nikolaropoulos SS
    Mutat Res; 2007 Apr; 617(1-2):125-37. PubMed ID: 17324445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxicity, DNA crosslinking ability and DNA sequence selectivity of the aniline mustards melphalan, chlorambucil and 4-[bis(2-chloroethyl)amino] benzoic acid.
    Sunters A; Springer CJ; Bagshawe KD; Souhami RL; Hartley JA
    Biochem Pharmacol; 1992 Jul; 44(1):59-64. PubMed ID: 1632839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulfur and nitrogen mustards induce characteristic poly(ADP-ribosyl)ation responses in HaCaT keratinocytes with distinctive cellular consequences.
    Mangerich A; Debiak M; Birtel M; Ponath V; Balszuweit F; Lex K; Martello R; Burckhardt-Boer W; Strobelt R; Siegert M; Thiermann H; Steinritz D; Schmidt A; Bürkle A
    Toxicol Lett; 2016 Feb; 244():56-71. PubMed ID: 26383629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
    Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
    Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat.
    Greig NH; Sweeney DJ; Rapoport SI
    Cancer Chemother Pharmacol; 1988; 21(1):1-8. PubMed ID: 3342460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice.
    Nath K; Nelson DS; Putt ME; Leeper DB; Garman B; Nathanson KL; Glickson JD
    PLoS One; 2016; 11(6):e0157125. PubMed ID: 27285585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of murine B- and T-lymphocytes to oxazaphosphorine and non-oxazaphosphorine nitrogen mustards.
    Smith PC; Sladek NE
    Biochem Pharmacol; 1985 Oct; 34(19):3459-63. PubMed ID: 3876834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors determining cell killing by chemotherapeutic agents in vivo. II. Melphalan, chlorambucil and nitrogen mustard.
    van Putten LM; Lelieveld P
    Eur J Cancer (1965); 1971 Feb; 7(1):11-6. PubMed ID: 5576726
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel melphalan and chlorambucil derivatives of 2,2,6,6-tetramethyl-1-piperidinyloxy radicals: synthesis, characterization, and biological evaluation in vitro.
    Zhao H; Meng X; Yuan H; Lan M
    Chem Pharm Bull (Tokyo); 2010 Mar; 58(3):332-5. PubMed ID: 20190437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic basis for the comparative antitumour activity and toxicity of chlorambucil, phenylacetic acid mustard and beta, beta-difluorochlorambucil (CB 7103) in mice.
    Lee FY; Coe P; Workman P
    Cancer Chemother Pharmacol; 1986; 17(1):21-9. PubMed ID: 3698173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of a nitrogen mustard derivative stabilized by apo-neocarzinostatin.
    Urbaniak MD; Bingham JP; Hartley JA; Woolfson DN; Caddick S
    J Med Chem; 2004 Sep; 47(19):4710-5. PubMed ID: 15341486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
    Shepherd R; Harrap KR
    Br J Cancer; 1982 Mar; 45(3):413-20. PubMed ID: 7073935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Letter: Effects of amylobarbitone on the frequency of chromosomal aberrations in human lymphocytes determined by chlorambucil and melphalan in vitro.
    Stoltz DR
    Mutat Res; 1974 Jun; 23(3):401. PubMed ID: 4407664
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Effects of amylobarbitone on the frequency of chromosomal aberrations in human lymphocytes determined by chlorambucil and melphalan in vitro.
    Stevenson AC
    Mutat Res; 1974 Jun; 23(3):403-4. PubMed ID: 4407665
    [No Abstract]   [Full Text] [Related]  

  • 16. On the biological alkylating agents.
    Haddow A
    Perspect Biol Med; 1973; 16(4):503-24. PubMed ID: 4593768
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards.
    Godenèche D; Madelmont JC; Moreau MF; Plagne R; Meyniel G
    Cancer Chemother Pharmacol; 1980; 5(1):1-9. PubMed ID: 7460189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue.
    Monks NR; Blakey DC; Curtin NJ; East SJ; Heuze A; Newell DR
    Br J Cancer; 2001 Sep; 85(5):764-71. PubMed ID: 11531265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of current alkylating agents with a homo-aza-steroidal ester for antineoplastic activity.
    Catsoulacos P; Papageorgiou A; Margarity E; Mourelatos D; Mioglou E
    Oncology; 1994; 51(1):74-8. PubMed ID: 8265107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the effect of therapy with nitrogen mustard or a derivative on chromosomes of human peripheral blood lymphocytes.
    Sharpe HB
    Cell Tissue Kinet; 1971 Sep; 4(5):501-4. PubMed ID: 5126971
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.